Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Tsung-Kun Lin"'
Autor:
Fang-Ling Li, Yu-Tse Sheih, Ming-Hsun Lin, Yong-Chen Chen, Wen-Tung Wu, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background We explored if the administration of fluoxetine, recognized for its potential in adipocyte browning, entails a differential risk of coronary heart disease (CHD) in comparison to other SSRI medications. Methods Using the National H
Externí odkaz:
https://doaj.org/article/df6a2c72a10b41319100c92fbc7e4468
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 8, Pp 830-836 (2024)
Oral cancer is a prevalent global issue, with oral squamous cell carcinoma constituting the majority of cases. Standard treatments like surgery, radiotherapy, and chemotherapy are available but may have adverse effects. Molecular gene therapy, focusi
Externí odkaz:
https://doaj.org/article/c09aa6e4ba894adb889f5e78e83954ac
Autor:
Tsung-Kun Lin, Mei-Chun Lee, Yu-Han Cheng, Timothy Ma, Mei-Chun Chen, Tsung-Yuan Yang, Gwo-Ping Jong
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-9 (2023)
Abstract Background Several observational cohorts and meta-analytical studies on humans have shown that users of sodium-glucose cotransporter-2 inhibitors (SGLT2is) have a lower risk for new-onset acute coronary syndrome (ACS) than nonusers. However,
Externí odkaz:
https://doaj.org/article/dc3b357a492340a39c4d59b4d05a59ff
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-7 (2023)
Abstract Background Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes. The aims of th
Externí odkaz:
https://doaj.org/article/ef15b16d79f9478dad4cbb7e4ef97d06
Autor:
Chih-Weim Hsiang, Wen-Yu Lin, Cheng-Hsiang Lo, Chun-Yu Liang, Tsung-Kun Lin, Chun-Hsien Hsieh, Jia-En Chen, Wen-Cheng Liu
Publikováno v:
Journal of Medical Sciences, Vol 43, Iss 1, Pp 28-36 (2023)
Background: Coronary artery calcification (CAC) is a well-validated parameter reflecting the extent of subclinical atherosclerosis. Atherosclerosis manifestations are commonly presented in atrial fibrillation (AF) patients. Nevertheless, the long-ter
Externí odkaz:
https://doaj.org/article/cc2f068b296242ae9fe3be3b5feed3f0
Autor:
Tsung-Kun Lin, Yong-Hsin Chen, Jing-Yang Huang, Pei-Lun Liao, Mei-Chun Chen, Lung-Fa Pan, Gwo-Ping Jong
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundEpidemiological evidence suggests the association of diabetes with an increased risk of stroke. Clinical studies have investigated the effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on new-onset stroke (NOS), but the results
Externí odkaz:
https://doaj.org/article/0e0bc8dff81a49288315cbb3d5d4addd
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-8 (2021)
Abstract Background Some observational studies have found a significant association between the use of statin and a reduced risk of dementia. However, the results of these studies are unclear in patients with rheumatoid arthritis (RA). This study is
Externí odkaz:
https://doaj.org/article/cabf91b1624f4e8bb601d2eb258c34b6
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1073 (2023)
Patients with chronic kidney disease (CKD) are at a higher risk for developing dementia than the general population. Clinical studies have investigated the effects of statin use on new-onset dementia (NOD) in patients with CKD; however, the findings
Externí odkaz:
https://doaj.org/article/09880de19d814d74b0e29430225d6435
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-7 (2020)
Abstract Background In the recent years, chronic obstructive pulmonary disease (COPD) has been found to be associated with a higher risk of new-onset osteoporotic fracture (NOF). However, the existence of such an association in the COPD patients rece
Externí odkaz:
https://doaj.org/article/eb7218e2a4b44a138719b1dba37b0a86
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196713 (2018)
Several observational cohort and meta-analytical studies in humans have shown that statin users have a lower risk of fractures or greater bone mineral densities (BMD) than nonusers. However, some studies including randomized clinical trials have the
Externí odkaz:
https://doaj.org/article/008d8c07b7354f9faae8834d42984802